(1)
Retracted, A. EFFICACY AND SAFETY OF ADALIMUMAB VERSUS INFLIXIMAB IN PATIENTS SUFFERED FROM MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS. Asian J Pharm Clin Res 2017, 10, 300-307.